Giamouzis G, Kourek C, Magouliotis D, Briasoulis A, Zakynthinos G, Sawafta A
J Clin Med. 2024; 13(23).
PMID: 39685852
PMC: 11642004.
DOI: 10.3390/jcm13237395.
Zhang N, Sui Y, Jendrichovsky P, Feng H, Shi H, Zhang X
Alzheimers Res Ther. 2024; 16(1):109.
PMID: 38750512
PMC: 11094875.
DOI: 10.1186/s13195-024-01472-1.
Kandalgaonkar M, Yeoh B, Joe B, Schmidt N, Vijay-Kumar M, Saha P
Function (Oxf). 2024; 5(3):zqae009.
PMID: 38706961
PMC: 11065114.
DOI: 10.1093/function/zqae009.
Gintoni I, Mastrogeorgiou M, Papakosta V, Vassiliou S, Yapijakis C
Biochem Genet. 2024; .
PMID: 38546913
DOI: 10.1007/s10528-024-10746-0.
Feng J, Zhao X, Huang B, Huang L, Wu Y, Wang J
Front Immunol. 2023; 14:1228018.
PMID: 37649485
PMC: 10463734.
DOI: 10.3389/fimmu.2023.1228018.
Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue.
Yasuoka Y, Izumi Y, Sands J, Kawahara K, Nonoguchi H
Molecules. 2023; 28(11).
PMID: 37298922
PMC: 10254663.
DOI: 10.3390/molecules28114446.
Red blood cell distribution width/platelet ratio on admission as a predictor for in-hospital mortality in patients with acute myocardial infarction: a retrospective analysis from MIMIC-IV Database.
Yao H, Lian L, Zheng R, Chen C
BMC Anesthesiol. 2023; 23(1):113.
PMID: 37016294
PMC: 10071654.
DOI: 10.1186/s12871-023-02071-7.
Administration of α-Klotho Does Not Rescue Renal Anemia in Mice.
Park M, Le Henaff C, Sitara D
Front Pediatr. 2022; 10:924915.
PMID: 35813388
PMC: 9259788.
DOI: 10.3389/fped.2022.924915.
Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat.
Cozier G, Newby E, Schwager S, Isaac R, Sturrock E, Acharya K
FEBS J. 2022; 289(21):6659-6671.
PMID: 35653492
PMC: 9796954.
DOI: 10.1111/febs.16543.
Red Blood Cell Distribution Width in Heart Failure: Pathophysiology, Prognostic Role, Controversies and Dilemmas.
Xanthopoulos A, Giamouzis G, Dimos A, Skoularigki E, Starling R, Skoularigis J
J Clin Med. 2022; 11(7).
PMID: 35407558
PMC: 8999162.
DOI: 10.3390/jcm11071951.
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients.
Akbari M, Taheri M, Mehrpoor G, Eslami S, Hussen B, Ghafouri-Fard S
Vascul Pharmacol. 2021; 142:106934.
PMID: 34774774
PMC: 8579741.
DOI: 10.1016/j.vph.2021.106934.
Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver.
Yasuoka Y, Izumi Y, Fukuyama T, Inoue H, Oshima T, Yamazaki T
Molecules. 2021; 26(17).
PMID: 34500833
PMC: 8434508.
DOI: 10.3390/molecules26175399.
Discontinuation of the renin-angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.
Pavlidis G, Papageorgiou S, Bazani E, Bouchla A, Glezou E, Gkontopoulos K
Ther Adv Hematol. 2021; 12:2040620720958299.
PMID: 33489062
PMC: 7809530.
DOI: 10.1177/2040620720958299.
Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics.
Cozier G, Lubbe L, Sturrock E, Acharya K
FEBS J. 2020; 288(7):2238-2256.
PMID: 33067882
PMC: 8048788.
DOI: 10.1111/febs.15601.
Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases.
Jarajapu Y
Mol Pharmacol. 2020; 99(1):29-38.
PMID: 32321734
PMC: 7725063.
DOI: 10.1124/mol.119.117580.
Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease.
Nam K, Kim H, An S, Lee M, Cha M, Park J
Sci Rep. 2018; 8(1):7294.
PMID: 29740119
PMC: 5940871.
DOI: 10.1038/s41598-018-25439-z.
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe L
FASEB J. 2018; 32(7):3752-3764.
PMID: 29481308
PMC: 5998980.
DOI: 10.1096/fj.201700667R.
Angiotensin-converting enzyme affects the presentation of MHC class II antigens.
Zhao T, Bernstein K, Fang J, Shen X
Lab Invest. 2017; 97(7):764-771.
PMID: 28394320
PMC: 5493495.
DOI: 10.1038/labinvest.2017.32.
Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats.
Younas F, Aslam B, Muhammad F, Mohsin M, Raza A, Faisal M
Pharm Biol. 2016; 55(1):108-113.
PMID: 27925507
PMC: 7011972.
DOI: 10.1080/13880209.2016.1230635.
High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4.
Tsai M, Leu J, Fang Y, Liou H
Medicine (Baltimore). 2016; 95(11):e3049.
PMID: 26986127
PMC: 4839908.
DOI: 10.1097/MD.0000000000003049.